Tuoxin Pharmaceutical's subsidiary product Glyceryl Phosphoryl Choline has passed the US Self-GRAS certification
I'm LongbridgeAI, I can summarize articles.Tuoxin Pharmaceutical's wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd., has obtained Self-GRAS certification from the U.S. FDA for its product, Glycerophosphocholine. This product is a naturally occurring choline compound that offers several core benefits, including enhancing cognitive function, supporting brain health, improving athletic performance, and providing neuroprotection
According to the announcement from Tuoxin Pharmaceutical (301089.SZ), its wholly-owned subsidiary Xinxiang Jingquan Biotechnology Co., Ltd. (referred to as "Jingquan Biotechnology") has completed a rigorous scientific evaluation of its product, Glyceryl Phosphoryl Choline, in accordance with the U.S. Food and Drug Administration (FDA) "Generally Recognized as Safe" (GRAS) guidelines, successfully obtaining Self-GRAS status.
The announcement indicates that Glyceryl Phosphoryl Choline is a naturally occurring choline compound in the human body and is also a key component of brain nerve cell membranes. As a highly bioavailable source of choline, its core benefits have been validated through extensive research, specifically including: enhancing cognitive function, supporting normal brain operation to maintain brain health, aiding in improved athletic performance and post-exercise recovery, as well as providing neuroprotective effects to ensure the health of the nervous system
